Alterations of Platelet Aggregation Kinetics with Ultraviolet Laser Emission: The “Stunned Platelet” Phenomenon

 

 Buy Article Permissions and Reprints

Summary

Platelets, a major constituent of thrombus, play a crucial role in the pathogenesis of acute ischemic coronary syndromes. The effect of ultraviolet laser emission on platelets within thrombi is unknown. The effects of increasing levels of laser energy on platelets in whole blood were investigated. Blood samples were obtained by aseptic venipuncture and anticoagulated with 3.8% sodium citrate. Samples were exposed to increased levels (0, 30, 45, 60 mJ/mm²; 25 Hz) of ultraviolet excimer laser fluence (308 nm wave-length) and then tested for ADP and collagen induced platelet aggregation, platelet concentration, and for platelet contractile force (PCF) development. Scanning electron microscopy was used to detect laser induced morphologic changes of platelets and by flow cytometric analysis to detect changes in expression of platelet surface antigens p-selectin (CD 62) and glycoprotein IIb/IIIa (CD 43). Exposure to excimer laser energy produced dose dependent suppression of platelet aggregation and force development (“stunned platelets”). ADP aggregation decreased from 8.0 ± 1.1 Ohms (mean ± SEM) to 3.7 ± 0.8 Ohms (p 0.001) to 2.7 ± 0.6 Ohms (p 0.001) and to 1.8 ± 0.5 Ohms (p 0.001) as the laser energy increased from 0 to 30 to 45 to 60 mJ/mm², respectively. Collagen induced aggregation decreased from 21.4 ± 1.4 Ohms to 15.7 ± 1.2 Ohms (p 0.001) to 11.7 ± 1.1 Ohms (p 0.001) and to 9.9 ± 1.0 Ohms (p 0.001), in response to the same incremental range of laser energy. Platelet contractile forces declined from 34,500 ± 3700 to 27,800 ± 2700 dynes as laser energy increased from 0 to 60 mJ/mm² (p 0.03). Platelet concentration did not change with increasing laser energy. The expression of platelet surface antigen p-selectin (CD 62) remained stable through increasing levels of laser energy exposures while the percentage of CD 43 positive platelets significantly increased with exposure to laser energy, yet the level of expression did not exceed 0.5% of cells. Thus, aggregation kinetics are altered in platelets exposed to ultraviolet laser energy as manifested by decreased platelet aggregation and reduction in platelet force development capability. The response is dose dependent and most pronounced at higher energy levels such as 60 mJ/mm².

• References

• 1 Fuster V. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation 1994; 90: 2126-46.
  CrossrefPubMedGoogle Scholar
• 2 Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of artery disease and the acute coronary syndromes, Parts 1 and 2. N Engl J Med 1992; 326: 242-50 310-8.
  CrossrefPubMedGoogle Scholar
• 3 Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Circulation 1985; 71: 699-708.
  CrossrefPubMedGoogle Scholar
• 4 Lefkovits J, Topol EJ. Role of platelet inhibitor agents in coronary artery disease. In: Textbook of Interventional Cardiology. Topol EJ. (ed). Philadelphia: W. B. Saunders; 1998: 3-24.
  Google Scholar
• 5 Litvack F, Eigler N, Margolis J, Rothbaum S, Bresnahan JF, Holmes D, Untereker W, Leon M, Kent K, Pichard A, King S, Ghazzal Z, Cummin F, Krauthamer D, Palacios I, Block P, Hartzler GO, O’Neill W, Cowley M, Roubin G, Klein LW, Frankel PS, Adams C, Goldenberg T, Laudenslager J, Grundfest WS, Forrester JS. Percutaneous excimer laser coronary angioplasty: results in the first consecutive 3000 patients. J Am Coll Cardiol 1994; 23: 323-9.
  CrossrefPubMedGoogle Scholar
• 6 Topaz O, Rozenbaum EA, Schumacher A, Luxenberg MG. Solid state, mid-infrared laser facilitated coronary angioplasty: clinical and quantitative coronary angiographic results in 112 patients. Laser Surg Med 1996; 19: 260-72.
  CrossrefPubMedGoogle Scholar
• 7 Bittl JA. Clinical results with excimer laser coronary angioplasty. Semin Intervent Cardiol 1996; 1: 129-34.
  PubMedGoogle Scholar
• 8 Topaz O. Laser. In: Textbook of Interventional Cardiology. Topol EJ. (ed). Philadelphia: W. B. Saunders; 1998: 615-33.
  Google Scholar
• 9 Topaz O, Bernardo NL, Shah R, McQueen RH, Desai P, Janin Y, Lansky AJ, Carr ME. Effectiveness of excimer laser coronary angioplasty in acute myocardial infarction or in unstable angina pectoris. Am J Cardiol 2001; 87: 849-55.
  CrossrefPubMedGoogle Scholar
• 10 Topaz O, Shah R, Mohanty PK, McQueen RA, Janin Y, Bernardo NL. Application of excimer laser angioplasty in acute myocardial infarction. Lasers Surg Med. 2001 In Press.
  PubMedGoogle Scholar
• 11 Carr ME, Zekert SL. Measurement of platelet-mediated force development during plasma clot formation. Am J Med Sci 1991; 302: 13-8.
  CrossrefPubMedGoogle Scholar
• 12 Carr ME, Zekert SL. Force monitoring of clot retraction during DDAVP therapy for the qualitative platelet disorder of uraemia: report of a case. Blood Coagul Fibrinol 1991; 2: 303-8.
  CrossrefPubMedGoogle Scholar
• 13 Carr ME. Measurement of platelet force: the Hemodyne hemostasis analyzer. Clin Lab Management Rev 1995; 9: 312-9.
  PubMedGoogle Scholar
• 14 Willerson JT, Colino P, Eidt J, Campbell WB, Buja LM. Specific platelet mediators and unstable coronary artery lesions: experiments evidence and potential clinical implications. Circulation 1989; 80: 198-205.
  CrossrefPubMedGoogle Scholar
• 15 Elwood PC, Renaud S, Sharp DS, Beswick AD, O’Brien JR, Yarnell JWG. Ischemic heart disease and platelet aggregation: The Caerphilly Collaborative heart disease study. Circulation 1991; 83: 38-44.
  CrossrefPubMedGoogle Scholar
• 16 The EPIC Investigators.. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994; 330-6.
  PubMedGoogle Scholar
• 17 Lincoff AM, Popma JJ, Ellis SG, Hacker JA, Topol EJ. Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profile. J Am Coll Cardiol 1992; 19: 926-35.
  CrossrefPubMedGoogle Scholar
• 18 Myler RK, Shaw RE, Sterzer SH. Unstable angina and coronary angioplasty. Circulation 1990; 82 (Suppl. 02) II-88-II-95.
  CrossrefPubMedGoogle Scholar
• 19 Van DeWerf F. More evidence for the beneficial effect of platelet glycoprotein IIb/IIIa blockade during coronary angioplasty. Latest results from EPILOG and CAPTURE trials. Eur Heart J 1996; 17: 325-6.
  CrossrefPubMedGoogle Scholar
• 20 Morgenstern E, Korell U, Richter J. Platelets and fibrin during clot retraction. Thromb Res 1984; 33: 617-23.
  CrossrefPubMedGoogle Scholar
• 21 Cohen I, Gerrard JM, White JG. Ultrastructure of clots during isometric contraction. J Cell Biol 1982; 93: 775-87.
  CrossrefPubMedGoogle Scholar
• 22 Shepro D, Tullis JL, Belamarich FA, Curby WA. Similarities between platelet contraction and cellular motility during mitosis: role of platelet microtubules in clot retraction. J Cell Sci 1976; 20: 569-88.
  PubMedGoogle Scholar
• 23 Greilich P, Carr ME, Zekert SL. Effects of aspirin on clot structure and fibrin platelet interactions in patients with severe coronary artery disease. Clin Res 1992; 40: 241A.
  PubMedGoogle Scholar
• 24 Carr Jr ME, Carr SL, Hantgan RR, Braaten J. Glycoprotein IIb/IIIa blockade inhibits platelet mediated force development and reduces elastic modulus. Thromb Haemost 1995; 73: 499-505.
  Article in Thieme ConnectPubMedGoogle Scholar
• 25 Gregory KW. Laser thrombolysis. In: Textbook of Interventional Cardiology. Topol EJ. (ed). 2nd edition. Philadelphia: W. B. Saunders; 1995: 892-902.
  Google Scholar
• 26 De la Torre R, Gregory KW. Cavitation bubbles and acoustic transients may produce dissections during laser angioplasty. J Am Coll Cardiol 1992; 19 (Suppl A) 48A.
  CrossrefPubMedGoogle Scholar
• 27 Topaz O, Minisi AJ, Morris C, Mohanty PK, Carr Jr ME. Photoacoustic fibrinolysis, pulsed-wave, mid-infrared, laser-clot interaction. J Thromb Thrombol 1996; 3: 209-14.
  PubMedGoogle Scholar
• 28 Doerger PT, Glueck HI, McGill M. The effects of argon laser on in-vitro aggregation of platelets in platelet rich plasma and whole blood. Thrombus Res 1988; 50: 657-67.
  PubMedGoogle Scholar
• 29 Litvack F, Grundfest WS, Papaioannou T, Mohr FW, Jakubowski A, Forrester JS. Role of laser and thermal ablation devices in the treatment of vascular disease. Am J Cardiol 1988; 61: 81G-86G.
  CrossrefPubMedGoogle Scholar
• 30 Topaz O. Plaque removal and thrombus dissolution with pulsed-wave lasers’ photoacoustic energy – biotissue interactions and their clinical manifestations. Cardiology 1996; 87: 384-91.
  CrossrefPubMedGoogle Scholar
• 31 Topaz O, Ebersole D, Dahm J, Das T, Madyoon H, Perin EC. Excimer laser revascularization: current indications, applications and techniques. Lasers in Medical Science 2001; 16: 72-7.
  CrossrefPubMedGoogle Scholar
• 32 Estella P, Ryan TJ, Landzberg JS, Bittl JA. Excimer laser assisted coronary angioplasty for lesions containing thrombus. J Am Coll Cardiol 1993; 21: 1550-6.
  CrossrefPubMedGoogle Scholar
• 33 Deckelbaum L, Natarajan MK, Bittl JA, Rohlfs K, Scott J, Chisholm R, Bowman KA, Strauss BH. Effect of intracoronary saline infusion on dissection during excimer laser coronary angioplasty: a randomized trial. J Am Coll Cardiol 1995; 26: 1264-9.
  CrossrefPubMedGoogle Scholar
• 34 Holmes MB, Schneider DJ. Optimizing antiplatelet therapy in patients with acute coronary syndromes: a role for monitoring platelet reactivity. J Invas Cardiol 1999; 11: 21C-25C.
  PubMedGoogle Scholar